These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9796219)

  • 1. [Current developments in use of docetaxel (taxotere) in gynecologic oncology].
    Jackisch C
    Med Klin (Munich); 1998 Sep; 93 Suppl 3():4-15. PubMed ID: 9796219
    [No Abstract]   [Full Text] [Related]  

  • 2. Docetaxel (Taxotere) for advanced breast cancer.
    Med Lett Drugs Ther; 1996 Sep; 38(984):87-8. PubMed ID: 8828520
    [No Abstract]   [Full Text] [Related]  

  • 3. Taxol and taxotere--current status and future prospects.
    Bissett D; Kaye SB
    Eur J Cancer; 1993; 29A(9):1228-31. PubMed ID: 8102062
    [No Abstract]   [Full Text] [Related]  

  • 4. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From conquering metastatic disease to adjuvant therapy: clinical evolution of docetaxel in breast cancer].
    Cartenì G
    Tumori; 2001; 87(6):A1-5. PubMed ID: 11995695
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal herpes simplex virus hepatitis complicating chemotherapy with weekly docetaxel.
    Hofer S; Hunziker S; Tornillo L; Ludwig CU
    Ann Oncol; 2003 Feb; 14(2):340. PubMed ID: 12562665
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
    Moon C; Verschraegen CF; Bevers M; Freedman R; Kudelka AP; Kavanagh JJ
    Anticancer Drugs; 2000 Aug; 11(7):565-8. PubMed ID: 11036959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel. A review of its role in breast cancer treatment.
    Antoine EC; Rixe O; Auclerc G; Weil M; Khayat D
    Am J Clin Oncol; 1997 Aug; 20(4):429-32. PubMed ID: 9256905
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Docetaxel (taxotere) for therapy of breast carcinoma. Highest effectiveness with moderate side effects].
    von Minckwitz G; Costa SD
    Med Klin (Munich); 1997 Sep; 92 Suppl 4():4-9. PubMed ID: 9446016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-induced subungual hemorrhage.
    Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
    Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical rationale for developing docetaxel (Taxotere).
    Armand JP
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():37-9. PubMed ID: 8862710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel and docetaxel. Innovation, but at what cost?
    Lønning PE
    Pharmacoeconomics; 1995 Jul; 8(1):1-4. PubMed ID: 10155597
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer.
    Gogas H; Fountzilas G
    Ann Oncol; 2003 May; 14(5):667-74. PubMed ID: 12702519
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
    Langer-Nitsche C; Lück HJ; Heilmann M
    Acta Oncol; 2000; 39(8):1001. PubMed ID: 11206991
    [No Abstract]   [Full Text] [Related]  

  • 16. Docetaxel.
    Leahy M; Howell A
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):141-4. PubMed ID: 9166374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J; Clavel M; Chevalier B
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel and docetaxel in breast and ovarian cancer.
    Drug Ther Bull; 1997 Jun; 35(6):43-6. PubMed ID: 9282422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of docetaxel in the treatment of gastric cancer].
    Cascinu S
    Tumori; 2001; 87(6):A10-2. PubMed ID: 11995696
    [No Abstract]   [Full Text] [Related]  

  • 20. Docetaxel (Taxotere): an overview of first-line monotherapy.
    Trudeau ME
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):17-21. PubMed ID: 8604448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.